Clinical Trials Browser

Solid Tumor, Adult

NCT00571389 2026-03-18

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Recruiting

1,500 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT05689853 2026-03-18

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

87 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT06391918 2026-03-13

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Phase 1 Terminated

37 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT07137195 2026-02-27

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)

Phase NA Active not recruiting

47 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT04219254 2026-02-25

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

197 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT05381909 2026-02-20

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

Phase 1 Terminated

157 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT06265688 2026-02-20

First In Human Study of CX-2051 in Advanced Solid Tumors

Phase 1 Recruiting

160 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT06397963 2026-01-26

Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours

Phase NA Recruiting

18 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

Phase 2 Completed

16 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT07153094 2026-01-16

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)

Phase NA Active not recruiting

47 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT07294872 2026-01-16

A Study of TIL in Advanced Solid Tumors (CZ)

Phase 1 Not yet recruiting

30 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT04725474 2026-01-12

GDFATHER

Phase 1/2 Active not recruiting

263 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT07159828 2026-01-09

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

Phase 1 Active not recruiting

52 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT06265727 2026-01-08

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Phase 1/2 Recruiting

348 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT07152353 2026-01-07

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)

Phase NA Active not recruiting

47 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT05307874 2025-12-24

EVICTION-2

Phase 1/2 Completed

56 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT06977737 2025-12-08

ATTEST

Phase 1/2 Recruiting

72 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT05582850 2025-08-28

EPRAD

Phase 1 Completed

29 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT06088004 2025-08-22

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

Phase 1/2 Recruiting

218 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT03990233 2025-06-26

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

Phase 1 Completed

100 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT05435339 2025-04-22

A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy

Phase 1/2 Terminated

31 enrolled 29 charts

Other solid neoplasm

Solid Tumor, Adult

NCT06462716 2025-04-13

A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors

Phase 1 Active not recruiting

36 enrolled

Other solid neoplasm

Solid Tumor, Adult

Clinical Trials

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

First In Human Study of CX-2051 in Advanced Solid Tumors

Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)

A Study of TIL in Advanced Solid Tumors (CZ)

GDFATHER

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)

EVICTION-2

ATTEST

EPRAD

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy

A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors